Cargando…
Integration of the blood test into the low-dose computed tomography lung cancer screening: reliable discrimination between malignant and non-malignant radiographic findings
Autores principales: | Kuligina, Ekaterina S., Iyevleva, Aglaya G., Imyanitov, Evgeny N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577980/ https://www.ncbi.nlm.nih.gov/pubmed/34858791 http://dx.doi.org/10.21037/tlcr-21-680 |
Ejemplares similares
-
Cytotoxic and targeted therapy for hereditary cancers
por: Iyevleva, Aglaya G., et al.
Publicado: (2016) -
Hereditary cancer syndromes
por: Imyanitov, Evgeny N, et al.
Publicado: (2023) -
Molecular testing for colorectal cancer: Clinical applications
por: Imyanitov, Evgeny, et al.
Publicado: (2021) -
Thoracic Computed Tomography Findings in Malignant Mesothelioma
por: Tamer Dogan, Omer, et al.
Publicado: (2012) -
Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I
por: Orlova, Kristina V., et al.
Publicado: (2019)